CE4 COST-EFFECTIVENESS OF CAPECITABINE IN COMBINATION WITH DOCETAXEL VERSUS DOCETAXEL MONOTHERAPY IN PATIENTS WITH ADVANCED AND/OR METASTATIC BREAST CANCER IN FRANCE
Abstract
Authors
H Lilliu C Le Pen G Priol K Perez-Niddam R Aultman L Garrison